Pacira BioSciences (PCRX) Treasury Shares (2010 - 2026)

Pacira BioSciences' Treasury Shares history runs 7 years deep, the most recent figure standing at $227.0 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 803.68% year-over-year to $227.0 million; the TTM figure through Mar 2026 stood at $227.0 million (up 803.68% YoY), while the FY2025 annual figure was $176.6 million, up 602.86% from the prior year.
• Treasury Shares was $227.0 million for Q1 2026 at Pacira BioSciences, up from $176.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $9.0 million in Q1 2026 to a low of $837000.0 in Q2 2024.
• Historically, Treasury Shares has averaged $2.4 million across 5 years, with a median of $1.2 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares surged 200.61% in 2025, then soared 803.68% in 2026.
• A 3-year view of Treasury Shares shows it stood at $25.1 million in 2024, then surged by 602.86% to $176.6 million in 2025, then gained by 28.57% to $227.0 million in 2026.
• The last three Treasury Shares figures came in at $227.0 million (Q1 2026), $176.6 million (Q4 2025), and $125.5 million (Q3 2025), per Business Quant data.